$RFL News Article - Rafael Pharmaceuticals Reaches Milestone of 100 Patients Enrolled in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ? (devimistat) for Patients with Metastatic Pancreatic Cancer
https://marketwirenews.com/news-releases/rafa...25212.html